1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO
56.75 -0.90 (-1.56%)
324.5K
XNAS Volume

XNAS 15 Jul, 2025 12:57 PM (EDT)

Insider Trade
Helen Torley, President & CEO of Halozyme Therapeutics, sells 60K shares worth $3.4 million See details

Halozyme Therapeutics Inc. - HALO corporate action history

Check all corporate actions such as stock splits, dividends, mergers & acquisitions, and board meeting announcements for Halozyme Therapeutics Inc.